CRISPR gene-editing improves cancer immunotherapy : Shots - Health News Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients.

As part of the clinical trial, gene editing was used to improve the efficiency of the cancer-targeting T cells. This was done in two different ways.

CRISPR is revolutionizing medicine by enabling precise DNA edits, treating genetic diseases like sickle cell anemia and ...

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

Today, after getting the experimental treatment more than a year ago, both remain in remission, raising hopes the gene-editing technique may offer new hope to at least some cancer patients. On Monday, ...

New gene-editing therapy shows early success in fighting advanced GI cancers. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 05 / 250502133947.htm ...

For the first time, a new gene editing technology called base editing was used to modify immune cells and successfully treat a teen with treatment-resistant leukemia. A month afterward, 13-year ...

“By uncovering specific genetic vulnerabilities like the CDS1 and CDS2 relationship, we’re opening the door to new therapies ...

Gene Editing Could Stop Cancer, Diabetes and Bioterrorism: An Interview With CRISPR Scientist Jennifer Doudna. Published Aug 05, 2017 at 8:50 AM EDT.

Using CRISPR to modify certain immune cells could make cancer-fighting immunotherapy more potent for a broader set of patients. Two people who went through the treatment share their stories.